Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.74
Price to sales ratio
16.88

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4921
CDIO
Cardio Diagnostics Holdings Inc. - Common stock
1.85 USD-4.15%-15.53%+19.35%-29.52%5.48 M USD
4928
PULM
Pulmatrix, Inc. - Common Stock
1.48 USD-3.27%-3.90%-14.45%-69.98%5.41 M USD
4932
GOVX
GeoVax Labs, Inc. - Common Stock
0.72 USD+14.29%+14.29%-1.37%-50.34%5.31 M USD
4934
BCAB
BioAtla, Inc. - Common Stock
3.14 USD+0.32%-3.09%-7.37%+630.23%5.23 M USD

Frequently asked questions about BioRestorative Therapies, Inc. Common Stock (NV)

What is the BioRestorative Therapies, Inc. Common Stock (NV) stock price today?

The current price of BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is 0.21. Over the past 24 hours, the stock has changed by -4.55%. Follow the BRTX chart for real-time price dynamics.

What is the stock ticker of BioRestorative Therapies, Inc. Common Stock (NV)?

BioRestorative Therapies, Inc. Common Stock (NV) trades under the ticker BRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is BioRestorative Therapies, Inc. Common Stock (NV) stock going up?

BRTX has changed by 0.00% over the last week, -19.23% over the last month, and -88.46% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of BioRestorative Therapies, Inc. Common Stock (NV)?

BioRestorative Therapies, Inc. Common Stock (NV) currently has a market capitalization of 5.35 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were BioRestorative Therapies, Inc. Common Stock (NV) earnings last quarter?

Last quarter, BioRestorative Therapies, Inc. Common Stock (NV) reported earnings of -0.12 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was BioRestorative Therapies, Inc. Common Stock (NV) revenue for the last quarter?

BioRestorative Therapies, Inc. Common Stock (NV) reported quarterly revenue of 23.17 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was BioRestorative Therapies, Inc. Common Stock (NV) net income for the last quarter?

BioRestorative Therapies, Inc. Common Stock (NV) reported net income of -2.15 M for the last quarter. The previous quarter showed -3.21 M, which means net income changed by +32.84%.

How many employees does BioRestorative Therapies, Inc. Common Stock (NV) have?

As of the latest available data, BioRestorative Therapies, Inc. Common Stock (NV) has 14 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy BioRestorative Therapies, Inc. Common Stock (NV) stock?

You can buy BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in BioRestorative Therapies, Inc. Common Stock (NV) stock?

Investing in BioRestorative Therapies, Inc. Common Stock (NV) requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BRTX chart and related analysis on metatrader.com as part of your research.

News